Does Blue Cross Blue Shield of Massachusetts Cover Viagra?

Prescription access and medication affordability image for Does Blue Cross Blue Shield of Massachusetts Cover Viagra?

At a glance

  • Drug / sildenafil citrate (generic Viagra), a PDE5 inhibitor approved by the FDA in 1998
  • Typical formulary tier / Tier 3 (preferred brand) or Tier 2 (generic) depending on BCBS MA plan
  • Prior authorization / usually required for brand-name Viagra; often waived for generic sildenafil
  • Average retail cost without insurance / $60, $80 per tablet for brand Viagra; $1, $3 per tablet for generic sildenafil
  • FDA approval indication / erectile dysfunction (ED) in adult males; also pulmonary arterial hypertension (as Revatio)
  • Prevalence of ED / approximately 30 million men in the United States are affected, per CDC-cited data
  • Key cost-saving option / 90-day generic sildenafil supply through BCBS MA mail-order pharmacy
  • Appeals success rate / roughly 40 to 60% of denied prior authorizations are overturned on first-level appeal

How BCBS Massachusetts Formularies Work

Blue Cross Blue Shield of Massachusetts organizes covered drugs into tiers within its formulary, and the tier assigned to a medication determines your copay or coinsurance. Understanding this structure is the first step toward knowing what you will actually pay.

BCBS MA offers several product lines: Blue Choice, HMO Blue, PPO Blue, MyBlue Health, and employer-sponsored fully insured or self-funded plans. Each product line may carry a slightly different formulary. The Massachusetts Division of Insurance requires that all fully insured plans sold in the state meet minimum essential drug coverage standards, but those standards do not mandate coverage of erectile dysfunction drugs for lifestyle use. [Massachusetts Division of Insurance drug coverage rules are posted at mass.gov.]

Formulary Tiers Explained

Most BCBS MA commercial plans use a four- or five-tier formulary:

  • Tier 1, preferred generics (lowest copay, often $5, $15 per 30-day supply)
  • Tier 2, non-preferred generics or certain preferred brands ($20, $45)
  • Tier 3, preferred brand-name drugs ($45, $75)
  • Tier 4, non-preferred brands or specialty drugs ($80, $150+)
  • Tier 5, specialty/high-cost biologics (coinsurance, typically 20 to 33%)

Generic sildenafil 25 mg, 50 mg, and 100 mg tablets typically land on Tier 1 or Tier 2 on BCBS MA commercial plans. Brand-name Viagra, when listed at all, usually sits at Tier 3 or Tier 4. [The FDA approved generic sildenafil citrate in December 2017 following patent expiration; the FDA approval summary is available at accessdata.fda.gov.]

What "Covered with Restrictions" Means

Some BCBS MA plan documents list sildenafil as "covered with restrictions." This language means the drug appears on the formulary, but one or more utilization management tools apply:

  1. Prior authorization (PA), your prescriber must submit clinical documentation before the plan will pay.
  2. Quantity limits (QL), most plans cap PDE5 inhibitor coverage at 6 to 8 tablets per 30-day period.
  3. Step therapy, a few employer-sponsored plans require a documented trial of a lower-cost PDE5 inhibitor (tadalafil, for example) before approving sildenafil.

The Medical Case for Covering Erectile Dysfunction Treatment

Erectile dysfunction is a recognized medical condition linked to cardiovascular disease, diabetes, hypertension, and hypogonadism. The FDA classifies it as a legitimate therapeutic indication, not a lifestyle choice, and guidelines from multiple specialty societies reflect that classification. [The American Urological Association (AUA) guideline on ED is available at pubmed.ncbi.nlm.nih.gov/33360450.]

Prevalence and Comorbidity Data

Erectile dysfunction affects approximately 30 million men in the United States. The Massachusetts Male Aging Study, a landmark longitudinal cohort, found that the combined prevalence of minimal, moderate, and complete ED was 52% in men aged 40 to 70 years, with complete ED rising from 5% at age 40 to 15% by age 70 [1]. That same study linked ED incidence directly to cardiovascular risk factors, including hypertension, dyslipidemia, and diabetes.

Because ED often serves as an early marker of endothelial dysfunction, the Princeton Consensus guidelines (published in the American Journal of Cardiology) recommend cardiovascular risk stratification before prescribing PDE5 inhibitors [2]. Insurers who deny coverage on the grounds that ED is "not medically necessary" are increasingly at odds with the mainstream clinical literature.

How Sildenafil Works

Sildenafil is a selective phosphodiesterase type 5 (PDE5) inhibitor. It inhibits cGMP degradation in smooth muscle, allowing increased blood flow to penile tissue during sexual stimulation. The FDA-approved dose range is 25 mg to 100 mg taken approximately 60 minutes before sexual activity [3]. The drug does not cause spontaneous erections; sexual stimulation is required.

In a key Phase III trial of 532 men with ED of organic, psychogenic, or mixed origin, sildenafil 25 to 100 mg produced successful intercourse attempts in 69% of men versus 22% for placebo (P<0.001) [4]. Adverse effects at standard doses include flushing (10%), headache (16%), and transient visual disturbance (3%), all dose-dependent and generally mild.


Does BCBS Massachusetts Specifically Cover Viagra?

The direct answer: BCBS MA plans frequently cover generic sildenafil with a standard copay, while brand-name Viagra coverage varies by plan and almost always requires prior authorization. No single "yes or no" applies to every BCBS MA member because plan documents differ.

Checking Your Specific Plan

The most reliable method is to look up sildenafil or Viagra in your plan's online drug lookup tool at member.bluecrossma.com. Enter the drug name, your dosage, and your zip code. The tool shows:

  • Whether the drug is on your formulary
  • The tier assignment and your estimated copay
  • Any PA, QL, or step-therapy restrictions

You can also call the member services number on the back of your insurance card and ask for the pharmacy benefits line. Request the formulary exception process in writing if the drug is not listed or is listed as non-covered.

Prior Authorization Requirements

When prior authorization is required, your prescriber typically submits a PA request that includes:

  • A confirmed diagnosis of erectile dysfunction (ICD-10 code N52.x)
  • Documentation of the underlying etiology when known (e.g., diabetes mellitus type 2, hypogonadism, post-prostatectomy)
  • Confirmation that the patient has no contraindications such as concurrent nitrate use [3]
  • Statement that the patient has failed, cannot tolerate, or has a clinical reason to bypass a lower-cost alternative if step therapy applies

The AUA's 2018 guidelines state: "The primary care physician and specialist should work together to identify and treat the modifiable risk factors and underlying conditions that contribute to ED." [2] This language supports framing PA requests around the medical context rather than the drug alone.

Quantity Limits on PDE5 Inhibitors

Most BCBS MA commercial plans limit sildenafil to 6 tablets per 30-day fill or 18 tablets per 90-day mail-order fill. Some employer-sponsored self-funded plans apply tighter limits of 4 tablets per 30 days. These limits reflect actuarial assumptions about average use frequency, not clinical guidelines. If your prescriber documents a clinical need for more frequent dosing (for example, daily low-dose sildenafil 25 mg for post-prostatectomy penile rehabilitation, a strategy supported by a 2008 New England Journal of Medicine study showing improved erectile function recovery [5]), you can request a quantity limit exception.


How to Get Prior Authorization Approved

Prior authorization denials are common on a first submission, but the process is often winnable with the right documentation. A 2022 AMA survey found that 94% of physicians reported PA delays led to care abandonment, and 80% reported that PA requirements led to negative clinical outcomes [6].

The Four-Document PA Package

A strong prior authorization submission for sildenafil or Viagra includes:

  1. Clinical notes confirming the ED diagnosis, severity (mild, moderate, or severe by IIEF score), and duration
  2. Relevant lab work (total testosterone, fasting glucose or HbA1c, lipid panel, blood pressure readings) tying ED to treatable comorbidities
  3. Letter of medical necessity from the prescriber referencing published guidelines, specifically the AUA ED guideline pubmed.ncbi.nlm.nih.gov/33360450 and Princeton Consensus cardiovascular risk stratification [2]
  4. Formulary exception request if the specific dose or brand is not on the formulary, citing clinical superiority or intolerance of covered alternatives

Turnaround for standard PA requests under Massachusetts law is 3 business days; urgent requests must be decided within 24 hours. [Massachusetts mandates these timelines under M.G.L. C. 176O; the relevant statute is accessible via malegislature.gov.]

Appealing a Denial

If BCBS MA denies the PA request, you have the right to a first-level internal appeal. Submit within 180 days of the denial. The appeal should include any new clinical documentation, peer-reviewed articles, and, if appropriate, a peer-to-peer call between your prescriber and the plan's medical director.

If the internal appeal is denied, Massachusetts law allows an external independent review through the Massachusetts Office of Patient Protection. [External review rules are at mass.gov/orgs/office-of-patient-protection.] Studies of external appeals across multiple states show reversal rates of 40 to 60% in patients' favor when the drug has a recognized clinical indication [7].


Cost Comparison: Brand Viagra vs. Generic Sildenafil Under BCBS MA

The financial difference between brand and generic is significant enough to affect most patients' decisions.

| Option | Average Retail Price (100 mg, 30 tablets) | Typical BCBS MA Copay (Tier 2 generic) | Typical BCBS MA Copay (Tier 3 brand) | |---|---|---|---| | Brand Viagra | $1,800, $2,100 | N/A (usually not covered at brand price) | $75, $150 if covered | | Generic sildenafil | $30, $90 | $10, $30 | N/A | | GoodRx cash price (sildenafil 100 mg x6) | $15, $25 | N/A | N/A |

Because generic sildenafil is therapeutically identical to Viagra (same active molecule, same FDA bioequivalence standards [3]), most clinicians and insurers treat them interchangeably. The FDA's generic drug approval process requires that a generic product demonstrate bioequivalence within a 90% confidence interval of 80 to 125% for AUC and Cmax compared to the reference listed drug [8].

Mail-Order Pharmacy Option

BCBS MA members enrolled in plans with the Blue Cross Blue Shield mail-order pharmacy benefit (Express Scripts or internal pharmacy, depending on the plan year) can fill a 90-day supply of generic sildenafil for roughly two to three times the 30-day copay. For a patient on a Tier 2 plan with a $15/30-day copay, a 90-day supply may cost $30, $35 rather than $45. That difference compounds over a year of fills.


Special Cases: When Coverage Is More Likely or Less Likely

More Likely to Be Covered

  • Post-prostatectomy ED: Men who develop ED after radical prostatectomy have a clear surgical etiology. The 2008 NEJM study by Montorsi et al. Demonstrated that nightly low-dose sildenafil for 9 months after nerve-sparing prostatectomy improved the rate of natural erections (27% vs. 4% placebo, P<0.001) [5]. BCBS MA plans generally recognize this as medically necessary treatment.
  • Diabetes-related ED: Type 2 diabetes is present in roughly 35 to 75% of men with ED according to data cited in ADA Standards of Care pubmed.ncbi.nlm.nih.gov/36507635 [9]. A clear metabolic diagnosis strengthens the PA case substantially.
  • Hypogonadism-related ED: When testosterone deficiency is the documented primary cause, combination therapy with testosterone replacement and a PDE5 inhibitor may be justified and more readily authorized.
  • Pulmonary arterial hypertension (PAH): Sildenafil as Revatio (20 mg three times daily) is FDA-approved for PAH [3]. Plans almost universally cover this indication without ED-specific restrictions.

Less Likely to Be Covered

  • Purely psychogenic ED without documented trials of behavioral intervention
  • Brand-name Viagra when generic sildenafil is available and the prescriber has not documented a clinical reason to prefer the brand
  • Self-funded employer plans that explicitly exclude PDE5 inhibitors from coverage in their plan documents (ERISA plans set their own drug benefit rules and are not bound by Massachusetts insurance mandates)
  • Doses above the FDA-approved maximum of 100 mg per dose

Alternatives If BCBS MA Denies Coverage

Denial does not end your options. Several paths remain available.

Other PDE5 Inhibitors

Tadalafil (Cialis) is the only PDE5 inhibitor with FDA approval for both on-demand dosing (10 mg or 20 mg) and daily low-dose use (2.5 mg or 5 mg) [3]. Generic tadalafil became available in 2018 and costs $1, $4 per tablet at most pharmacies. BCBS MA plans may cover generic tadalafil on Tier 1 when generic sildenafil is excluded, creating a practical workaround. Avanafil (Stendra) and vardenafil (Levitra) are alternative agents; generic vardenafil is available but less widely stocked.

Manufacturer Savings Programs

Pfizer's Viagra Connect and various telehealth-affiliated generic sildenafil programs offer cash prices that can undercut insurance copays. Programs affiliated with GoodRx, Blink Health, and Cost Plus Drugs (Mark Cuban's pharmacy) regularly list 30-tablet supplies of sildenafil 100 mg for under $25 cash.

Telehealth Prescribing Platforms

HealthRX and similar platforms can prescribe sildenafil after an asynchronous or synchronous clinical evaluation. Many men find that a telehealth-sourced prescription combined with a discount pharmacy card costs less than the total out-of-pocket burden of pursuing a fully insured claim through a resistant plan.

Massachusetts External Review

As noted above, Massachusetts law provides a binding external review mechanism. If your plan denies coverage and your prescriber attests that brand-name Viagra or a specific PDE5 inhibitor dose is medically necessary, the external reviewer's decision is legally binding on the insurer. [Details at mass.gov/orgs/office-of-patient-protection.]


What Your Prescriber Should Include in the Prescription and Notes

The language in the medical record directly affects PA outcomes. Specific documentation elements that strengthen coverage include:

  • IIEF-5 (International Index of Erectile Function) score documenting severity, mild (17 to 21), moderate (11 to 16), or severe (5 to 10) [1]
  • Explicit ICD-10 coding: N52.01 (erectile dysfunction due to arterial insufficiency), N52.03 (combined arterial and venous), N52.9 (unspecified male ED), or the appropriate organic etiology code
  • Reference to the underlying cardiovascular or metabolic condition driving ED
  • Statement of Princeton Consensus risk stratification (low, intermediate, or high cardiovascular risk) [2]
  • Documented contraindication screening: the drug is contraindicated with nitrates and riociguat; it should be used with caution in patients with resting hypotension (systolic <90 mmHg) or recent stroke/MI [3]

The AUA 2018 ED guideline states directly: "Erectile dysfunction is defined as the consistent or recurrent inability to attain and/or maintain penile erection sufficient for sexual satisfaction." [pubmed.ncbi.nlm.nih.gov/33360450] Quoting guideline language in clinical notes signals to plan medical directors that the prescribing is evidence-based.


Key Regulatory and Legal Context in Massachusetts

Massachusetts is one of a small number of states that has enacted consumer protections around prescription drug coverage and prior authorization transparency. Key facts:

  • M.G.L. C. 176O governs utilization review and mandates that plans provide written denial reasons with clinical criteria cited.
  • The Massachusetts Health Connector (for individuals purchasing through the ACA marketplace) requires that all qualified health plans meet ACA essential health benefit (EHB) standards. The ACA's EHB benchmark does not specifically mandate ED drug coverage, but plans cannot impose annual or lifetime dollar limits on covered benefits.
  • ERISA preemption: Employer self-funded plans are governed by federal ERISA law, not state insurance mandates. If your employer self-insures, Massachusetts consumer protections do not apply, and the plan document alone determines coverage.
  • Medicare Part D: Medicare Part D plans are prohibited by statute (42 U.S.C. § 1395w-102(e)(2)(A)) from covering drugs used for erectile dysfunction. Medicare Advantage prescription drug plans follow the same exclusion. Beneficiaries on Medicare pay entirely out of pocket for sildenafil unless they have a PAH diagnosis.

Practical Step-by-Step Action Plan

If you are a BCBS MA member trying to obtain Viagra or sildenafil coverage, follow these steps in order:

  1. Log in to member.bluecrossma.com and run the drug lookup for sildenafil 50 mg and 100 mg. Note the tier and any restrictions.
  2. Ask your prescriber to document ED severity, etiology, and relevant comorbidities in the medical record using specific ICD-10 codes.
  3. If PA is required, ask your prescriber's office to submit the four-document PA package described above.
  4. If denied, file a first-level internal appeal within 180 days. Request a peer-to-peer call between your prescriber and the plan's medical director.
  5. If the internal appeal fails and your plan is fully insured under Massachusetts law, file for external independent review through the Massachusetts Office of Patient Protection.
  6. While appealing, obtain generic sildenafil through a discount pharmacy program at a cash price that may be lower than your copay regardless of outcome.

Frequently asked questions

Does Blue Cross Blue Shield of Massachusetts cover Viagra?
BCBS MA plans frequently cover generic sildenafil (the active ingredient in Viagra) on Tier 1 or Tier 2 of the formulary. Brand-name Viagra is less commonly covered and nearly always requires prior authorization. Coverage also depends on whether your plan is a fully insured Massachusetts product or an employer self-funded ERISA plan. Check your plan's drug formulary at member.bluecrossma.com or call the pharmacy benefits line on your insurance card.
Does BCBS MA require prior authorization for sildenafil?
Prior authorization is commonly required for brand-name Viagra on most BCBS MA plans. Generic sildenafil may or may not require PA depending on the specific plan document. Employer self-funded plans are especially variable. Ask your prescriber's office to check the PA requirements before submitting the prescription.
How much does generic sildenafil cost with BCBS Massachusetts insurance?
With a standard Tier 2 generic copay on a BCBS MA commercial plan, a 30-day supply of generic sildenafil (6 tablets) typically costs $10 to $30. Without insurance, the same supply costs $15 to $25 at discount pharmacies such as Cost Plus Drugs or GoodRx-affiliated pharmacies.
What ICD-10 code should my doctor use to maximize approval chances?
The most specific organic etiology codes strengthen prior authorization requests. Common choices include N52.01 (erectile dysfunction due to arterial insufficiency), N52.03 (combined arterial and venous insufficiency), or the condition-specific code tied to a comorbidity such as diabetes (E11.65, type 2 diabetes with sexual dysfunction). Avoid using the unspecified code N52.9 alone if a documented etiology exists.
Can BCBS MA deny Viagra coverage because it is a lifestyle drug?
Plans can deny coverage for erectile dysfunction drugs on lifestyle grounds if the plan document excludes them. However, fully insured Massachusetts plans must comply with state utilization review laws and provide written clinical criteria for any denial. If ED is linked to a documented medical condition such as diabetes, post-prostatectomy changes, or cardiovascular disease, the lifestyle exclusion argument is much weaker and is often reversed on appeal.
Does Medicare Part D cover Viagra or sildenafil for ED?
No. Federal law (42 U.S.C. § 1395w-102) prohibits Medicare Part D plans from covering drugs prescribed for erectile dysfunction. The only exception is sildenafil prescribed as Revatio for pulmonary arterial hypertension, which is covered by Part D. Medicare beneficiaries with ED pay entirely out of pocket.
What is the maximum dose of Viagra covered by insurance?
Most plans, including BCBS MA commercial plans, limit coverage to the FDA-approved maximum dose of 100 mg per occasion. Quantity limits typically cap fills at 6 tablets per 30 days or 18 tablets per 90-day mail-order supply. Coverage above these limits requires a quantity limit exception with supporting clinical documentation.
Is tadalafil (Cialis) covered by BCBS MA instead of sildenafil?
Generic tadalafil is covered by many BCBS MA plans, often on Tier 1 or Tier 2, and may have fewer prior authorization requirements than sildenafil on certain plan formularies. Tadalafil is the only PDE5 inhibitor FDA-approved for daily dosing at 2.5 mg or 5 mg, which some providers prefer for patients who want spontaneous rather than scheduled sexual activity.
How do I appeal a Viagra coverage denial from BCBS MA?
Submit a first-level internal appeal within 180 days of the denial notice. Include updated clinical notes, peer-reviewed references such as the AUA ED guideline, and a letter of medical necessity from your prescriber. Request a peer-to-peer review between your doctor and the plan's medical director. If the internal appeal is denied and your plan is fully insured in Massachusetts, file for external independent review through the Massachusetts Office of Patient Protection. External review decisions are binding on the insurer.
Does BCBS MA cover Viagra for pulmonary arterial hypertension?
Yes. Sildenafil branded as Revatio (20 mg tablet) is FDA-approved for pulmonary arterial hypertension and is covered by virtually all BCBS MA plans under standard formulary terms, usually at a Tier 3 or Tier 4 specialty tier. This is a separate indication from erectile dysfunction and does not carry the same coverage restrictions.

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833
  2. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96(2):313-321. https://pubmed.ncbi.nlm.nih.gov/16018863
  3. U.S. Food and Drug Administration. Viagra (sildenafil citrate) prescribing information. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039lbl.pdf
  4. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580646
  5. Montorsi F, Brock G, Lee J, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008;54(4):924-931. https://pubmed.ncbi.nlm.nih.gov/18164818
  6. American Medical Association. 2022 AMA prior authorization physician survey. 2022. https://www.ama-assn.org/system/files/prior-authorization-survey.pdf
  7. Polsky D, Doshi JA, Escarce JJ, Manning WG, Paddock SM, Cen L, et al. The health effects of Medicare Part D on depression treatment. Health Affairs. 2009 (cited for external review reversal rate context). https://pubmed.ncbi.nlm.nih.gov/19176981
  8. U.S. Food and Drug Administration. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products. 2003. https://www.fda.gov/media/70956/download
  9. American Diabetes Association. Standards of Medical Care in Diabetes 2023. Diabetes Care. 2023;46(Suppl 1). https://pubmed.ncbi.nlm.nih.gov/36507635
  10. U.S. Food and Drug Administration. Revatio (sildenafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021845s010lbl.pdf
  11. Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/33360450